Company Profile
Alnylam Pharmaceuticals, Inc. Stock Price, News & Analysis
- Ticker:
- ALNY
- Exchange:
- NASDAQ
- Sector:
- RNA干扰技术平台
- Location:
- Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Alnylam is followed within the RNA therapeutics universe for its exposure to specialty-disease catalysts and platform growth.
Stock performance
288.18 USD (+0.62%)
Close
Last updated: June 23, 2026 at 00:00
38.48B USD
Market cap
Why the stock is moving
ALNY is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases. Investors watch platform execution, label expansion, and how new programs broaden the franchise.
Geographic Base and Sector Classification
Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Alnylam is followed within the RNA therapeutics universe for its exposure to specialty-disease catalysts and platform growth.
Business Model Characteristics
Alnylam combines commercial execution with platform development, so the market focuses on launch momentum, pipeline depth, and how efficiently the company turns RNA science into growth.
Position Within the Biotechnology Landscape
Compared with earlier-stage biotech names, Alnylam sits closer to the commercial-platform side of the landscape, where both launch quality and pipeline renewal matter.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Alnylam Pharmaceuticals, Inc. (ALNY)?
Alnylam Pharmaceuticals, Inc. (ALNY) most recently closed at 288.18 USD, a +0.62% move versus the previous session.
What is the market cap of Alnylam Pharmaceuticals, Inc. (ALNY)?
Alnylam Pharmaceuticals, Inc. currently has a market capitalization of 38.48B USD on BioPharmSignal.
What does Alnylam Pharmaceuticals, Inc. do?
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases. Investors watch platform execution, label expansion, and how new programs broaden the franchise.
On which exchange is ALNY stock listed?
Alnylam Pharmaceuticals, Inc. (ALNY) is associated with NASDAQ, Headquartered in Cambridge, Massachusetts and listed on NASDAQ, Alnylam is followed within the RNA therapeutics universe for its exposure to specialty-disease catalysts and platform growth., RNA干扰技术平台.
What is Alnylam?
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases.
Which conditions is Alnylam Pharmaceuticals, Inc. targeting with Alnylam?
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases. Investors watch platform execution, label expansion, and how new programs broaden the franchise.
What is Pharmaceuticals?
Alnylam Pharmaceuticals is an RNA medicines company focused on gene-silencing therapeutics across rare and specialty diseases.
What is Investors?
Investors watch platform execution, label expansion, and how new programs broaden the franchise.